Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial.

Hind D, Parkin J, Whitworth V, Rex S, Young T, Hampson L, Sheehan J, Maguire C, Cantrill H, Scott E, Epps H, Main M, Geary M, McMurchie H, Pallant L, Woods D, Freeman J, Lee E, Eagle M, Willis T, Muntoni F, Baxter P.

Pilot Feasibility Stud. 2017 Mar 27;3:16. doi: 10.1186/s40814-017-0132-0. eCollection 2017.

2.

Quantitative muscle ultrasound detects disease progression in Duchenne muscular dystrophy.

Zaidman CM, Wu JS, Kapur K, Pasternak A, Madabusi L, Yim S, Pacheck A, Szelag H, Harrington T, Darras BT, Rutkove SB.

Ann Neurol. 2017 May;81(5):633-640. doi: 10.1002/ana.24904. Epub 2017 May 4.

PMID:
28241384
3.

Electrical impedance myography for assessment of Duchenne muscular dystrophy.

Rutkove SB, Kapur K, Zaidman CM, Wu JS, Pasternak A, Madabusi L, Yim S, Pacheck A, Szelag H, Harrington T, Darras BT.

Ann Neurol. 2017 May;81(5):622-632. doi: 10.1002/ana.24874. Epub 2017 May 4.

PMID:
28076894
4.

Circulating Biomarkers for Duchenne Muscular Dystrophy.

Aartsma-Rus A, Spitali P.

J Neuromuscul Dis. 2015 Jul 22;2(s2):S49-S58.

5.

Using Touch-evoked Response and Locomotion Assays to Assess Muscle Performance and Function in Zebrafish.

Sztal TE, Ruparelia AA, Williams C, Bryson-Richardson RJ.

J Vis Exp. 2016 Oct 31;(116). doi: 10.3791/54431.

6.

Individualized Prediction of Changes in 6-Minute Walk Distance for Patients with Duchenne Muscular Dystrophy.

Goemans N, Vanden Hauwe M, Signorovitch J, Swallow E, Song J; Collaborative Trajectory Analysis Project (cTAP).

PLoS One. 2016 Oct 13;11(10):e0164684. doi: 10.1371/journal.pone.0164684. eCollection 2016.

7.

Feasibility and tolerability of whole-body, low-intensity vibration and its effects on muscle function and bone in patients with dystrophinopathies: a pilot study.

Petryk A, Polgreen LE, Grames M, Lowe DA, Hodges JS, Karachunski P.

Muscle Nerve. 2017 Jun;55(6):875-883. doi: 10.1002/mus.25431. Epub 2017 Feb 6.

PMID:
27718512
8.

Trendelenburg-Like Gait, Instability and Altered Step Patterns in a Mouse Model for Limb Girdle Muscular Dystrophy 2i.

Maricelli JW, Lu QL, Lin DC, Rodgers BD.

PLoS One. 2016 Sep 14;11(9):e0161984. doi: 10.1371/journal.pone.0161984. eCollection 2016.

9.

Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathies.

Bello L, Campadello P, Barp A, Fanin M, Semplicini C, Sorarù G, Caumo L, Calore C, Angelini C, Pegoraro E.

Sci Rep. 2016 Sep 1;6:32439. doi: 10.1038/srep32439.

10.

Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy.

Robinson-Hamm JN, Gersbach CA.

Hum Genet. 2016 Sep;135(9):1029-40. doi: 10.1007/s00439-016-1725-z. Epub 2016 Aug 20. Review.

PMID:
27542949
11.

A systematic review to investigate the measurement properties of goal attainment scaling, towards use in drug trials.

Gaasterland CM, Jansen-van der Weide MC, Weinreich SS, van der Lee JH.

BMC Med Res Methodol. 2016 Aug 17;16:99. doi: 10.1186/s12874-016-0205-4.

12.

Facioscapulohumeral dystrophy in children: design of a prospective, observational study on natural history, predictors and clinical impact (iFocus FSHD).

Goselink RJ, Schreuder TH, Mul K, Voermans NC, Pelsma M, de Groot IJ, van Alfen N, Franck B, Theelen T, Lemmers RJ, Mah JK, van der Maarel SM, van Engelen BG, Erasmus CE.

BMC Neurol. 2016 Aug 17;16:138. doi: 10.1186/s12883-016-0664-6.

13.

Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial.

Hafner P, Bonati U, Rubino D, Gocheva V, Zumbrunn T, Gueven N, Fischer D.

Trials. 2016 Aug 3;17(1):389. doi: 10.1186/s13063-016-1503-1.

14.

Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy.

Mercuri E, Signorovitch JE, Swallow E, Song J, Ward SJ; DMD Italian Group; Trajectory Analysis Project (cTAP).

Neuromuscul Disord. 2016 Sep;26(9):576-83. doi: 10.1016/j.nmd.2016.05.016. Epub 2016 May 27.

15.

A Movement Monitor Based on Magneto-Inertial Sensors for Non-Ambulant Patients with Duchenne Muscular Dystrophy: A Pilot Study in Controlled Environment.

Le Moing AG, Seferian AM, Moraux A, Annoussamy M, Dorveaux E, Gasnier E, Hogrel JY, Voit T, Vissière D, Servais L.

PLoS One. 2016 Jun 7;11(6):e0156696. doi: 10.1371/journal.pone.0156696. eCollection 2016.

16.

Noninvasive Assessment of Neuromuscular Disease in Dogs: Use of the 6-minute Walk Test to Assess Submaximal Exercise Tolerance in Dogs with Centronuclear Myopathy.

Cerda-Gonzalez S, Talarico L, Todhunter R.

J Vet Intern Med. 2016 May;30(3):808-12. doi: 10.1111/jvim.13939. Epub 2016 Mar 25.

17.

Timed Rise from Floor as a Predictor of Disease Progression in Duchenne Muscular Dystrophy: An Observational Study.

Mazzone ES, Coratti G, Sormani MP, Messina S, Pane M, D'Amico A, Colia G, Fanelli L, Berardinelli A, Gardani A, Lanzillotta V, D'Ambrosio P, Petillo R, Cavallaro F, Frosini S, Bello L, Bonfiglio S, De Sanctis R, Rolle E, Forcina N, Magri F, Vita G, Palermo C, Donati MA, Procopio E, Arnoldi MT, Baranello G, Mongini T, Pini A, Battini R, Pegoraro E, Torrente Y, Previtali SC, Bruno C, Politano L, Comi GP, D'Angelo MG, Bertini E, Mercuri E.

PLoS One. 2016 Mar 16;11(3):e0151445. doi: 10.1371/journal.pone.0151445. eCollection 2016.

18.

Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations.

Tomatsu S, Sawamoto K, Shimada T, Bober MB, Kubaski F, Yasuda E, Mason RW, Khan S, Alméciga-Díaz CJ, Barrera LA, Mackenzie WG, Orii T.

Expert Opin Orphan Drugs. 2015 Nov 1;3(11):1279-1290. Epub 2015 Oct 29.

19.

Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study.

Messina S, Vita GL, Sframeli M, Mondello S, Mazzone E, D'Amico A, Berardinelli A, La Rosa M, Bruno C, Distefano MG, Baranello G, Barcellona C, Scutifero M, Marcato S, Palmieri A, Politano L, Morandi L, Mongini T, Pegoraro E, D'Angelo MG, Pane M, Rodolico C, Minetti C, Bertini E, Vita G, Mercuri E.

Neuromuscul Disord. 2016 Mar;26(3):189-96. doi: 10.1016/j.nmd.2016.01.003. Epub 2016 Feb 2.

20.

Electrical impedance myography in facioscapulohumeral muscular dystrophy.

Statland JM, Heatwole C, Eichinger K, Dilek N, Martens WB, Tawil R.

Muscle Nerve. 2016 Oct;54(4):696-701. doi: 10.1002/mus.25065. Epub 2016 May 25.

PMID:
26840230

Supplemental Content

Support Center